High-purity DBCO-Val-Cit-PAB-MMAE from Axispharm is a precursor of an antibody drug conjugate containing a Val-Cit dipeptide, a DBCO group, and an MMAE payload. MMAE is a synthetic antineoplastic agent. It can attach to monoclonal antibodies (MABs), directing them to cancer cells. The DBCO group, on the other hand, is a highly reactive cycloalkyne that is commonly used in copper-free click chemistry.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
